{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:29:13Z","timestamp":1791494953613,"version":"4.3.4"},"reference-count":46,"publisher":"American Chemical Society (ACS)","issue":"12","license":[{"start":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T00:00:00Z","timestamp":1504137600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccby_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100011272","name":"FP7 Health","doi-asserted-by":"publisher","award":["115369"],"award-info":[{"award-number":["115369"]}],"id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C149\/A20740"],"award-info":[{"award-number":["C149\/A20740"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The absorption of poorly water-soluble drugs is influenced by the luminal gastrointestinal fluid content and composition, which control solubility. Simulated intestinal fluids have been introduced into dissolution testing including endogenous amphiphiles and digested lipids at physiological levels; however, in vivo individual variation exists in the concentrations of these components, which will alter drug absorption through an effect on solubility. The use of a factorial design of experiment and varying media by introducing different levels of bile, lecithin, and digested lipids has been previously reported, but here we investigate the solubility variation of poorly soluble drugs through more complex biorelevant amphiphile interactions. A four-component mixture design was conducted to understand the solubilization capacity and interactions of bile salt, lecithin, oleate, and monoglyceride with a constant total concentration (11.7 mM) but varying molar ratios. The equilibrium solubility of seven low solubility acidic (zafirlukast), basic (aprepitant, carvedilol), and neutral (fenofibrate, felodipine, griseofulvin, and spironolactone) drugs was investigated. Solubility results are comparable with literature values and also our own previously published design of experiment studies. Results indicate that solubilization is not a sum accumulation of individual amphiphile concentrations, but a drug specific effect through interactions of mixed amphiphile compositions with the drug. This is probably due to a combined interaction of drug characteristics; for example, lipophilicity, molecular shape, and ionization with amphiphile components, which can generate specific drug\u2013micelle affinities. The proportion of each component can have a remarkable influence on solubility with, in some cases, the highest and lowest points close to each other. A single-point solubility measurement in a fixed composition simulated media or human intestinal fluid sample will therefore provide a value without knowledge of the surrounding solubility topography meaning that variability may be overlooked. This study has demonstrated how the amphiphile ratios influence drug solubility and highlights the importance of the envelope of physiological variation when simulating in vivo drug behavior.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.7b00354","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T13:04:00Z","timestamp":1501160640000},"page":"4132-4144","source":"Crossref","is-referenced-by-count":28,"title":["Influence of Physiological Gastrointestinal Surfactant\nRatio on the Equilibrium Solubility of BCS Class II Drugs Investigated\nUsing a Four Component Mixture Design"],"prefix":"10.1021","volume":"14","author":[{"given":"Zhou","family":"Zhou","sequence":"first","affiliation":[{"name":"University of Strathclyde , , 161 Cathedral Street , ,","place":["Glasgow, United Kingdom, G4 0RE"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Dunn","sequence":"additional","affiliation":[{"name":"University of Strathclyde , , 161 Cathedral Street , ,","place":["Glasgow, United Kingdom, G4 0RE"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Khadra","sequence":"additional","affiliation":[{"name":"University of Strathclyde , , 161 Cathedral Street , ,","place":["Glasgow, United Kingdom, G4 0RE"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive G.","family":"Wilson","sequence":"additional","affiliation":[{"name":"University of Strathclyde , , 161 Cathedral Street , ,","place":["Glasgow, United Kingdom, G4 0RE"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8553-3647","authenticated-orcid":true,"given":"Gavin W.","family":"Halbert","sequence":"additional","affiliation":[{"name":"University of Strathclyde , , 161 Cathedral Street , ,","place":["Glasgow, United Kingdom, G4 0RE"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"issue":"1","key":"2026090221463581200_cit1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1023\/A:1011984216775","article-title":"Dissolution testing\nas a prognostic tool for oral drug absorption: Immediate release dosage\nforms","volume":"15","author":"Dressman","year":"1998","journal-title":"Pharm. Res."},{"key":"2026090221463581200_cit2","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ejps.2013.08.027","article-title":"A review of drug solubility\nin human intestinal fluids:\nImplications for the prediction of oral absorption","volume":"57C","author":"Augustijns","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"2026090221463581200_cit3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejps.2013.10.015","article-title":"Early pharmaceutical profiling to\npredict oral drug absorption: current status and unmet needs","volume":"57","author":"Bergstrom","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"11","key":"2026090221463581200_cit4","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1002\/jps.24183","article-title":"Composition and Physicochemical Properties\nof Fasted-State\nHuman Duodenal and Jejunal Fluid: A Critical Evaluation of the Available\nData","volume":"103","author":"Fuchs","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"2026090221463581200_cit5","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1007\/s11095-009-9857-7","article-title":"Postprandial\nchanges in solubilizing capacity of human intestinal fluids for BCS\nclass II drugs","volume":"26","author":"Clarysse","year":"2009","journal-title":"Pharm. Res."},{"issue":"5","key":"2026090221463581200_cit6","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation\nof various dissolution\nmedia for predicting in vivo performance of class I and II drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm. Res."},{"issue":"7","key":"2026090221463581200_cit7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1023\/A:1007576713216","article-title":"A comparison\nof the solubility of danazol in human and simulated gastrointestinal\nfluids","volume":"17","author":"Pedersen","year":"2000","journal-title":"Pharm. Res."},{"issue":"4","key":"2026090221463581200_cit8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1211\/0022357022935","article-title":"Dissolution media simulating\nthe intralumenal composition of the small intestine: physiological\nissues and practical aspects","volume":"56","author":"Vertzoni","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"issue":"4","key":"2026090221463581200_cit9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ejps.2004.11.007","article-title":"In vivo in vitro correlations\nfor a poorly soluble drug, danazol, using the flow-through dissolution\nmethod with biorelevant dissolution media","volume":"24","author":"Sunesen","year":"2005","journal-title":"Eur.\nJ. Pharm. Sci."},{"issue":"7","key":"2026090221463581200_cit10","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution\nmedia\nsimulating conditions in the proximal human gastrointestinal tract:\nan update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"issue":"12","key":"2026090221463581200_cit11","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1007\/s11095-011-0506-6","article-title":"Precipitation\nin and supersaturation\nof contents of the upper small intestine after administration of two\nweak bases to fasted adults","volume":"28","author":"Psachoulias","year":"2011","journal-title":"Pharm. Res."},{"issue":"12","key":"2026090221463581200_cit12","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1007\/s11095-012-0844-z","article-title":"An in vitro methodology for forecasting\nluminal concentrations and precipitation of highly permeable lipophilic\nweak bases in the fasted upper small intestine","volume":"29","author":"Psachoulias","year":"2012","journal-title":"Pharm. Res."},{"issue":"8","key":"2026090221463581200_cit13","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1002\/jps.22122","article-title":"Biorelevant\nmedia simulating\nfed state intestinal fluids: colloid phase characterization and impact\non solubilization capacity","volume":"99","author":"Kleberg","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"2026090221463581200_cit14","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s11095-005-8192-x","article-title":"The effects\nof food on the dissolution of poorly soluble\ndrugs in human and in model small intestinal fluids","volume":"22","author":"Persson","year":"2005","journal-title":"Pharm. Res."},{"key":"2026090221463581200_cit15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/jps.24603","article-title":"Characterization\nof Human Duodenal Fluids in Fasted\nand Fed State Conditions","volume":"105","author":"Riethorst","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"2026090221463581200_cit16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ejpb.2015.05.015","article-title":"Advances in the\ndesign of fasted state simulating intestinal fluids: FaSSIF-V3","volume":"94","author":"Fuchs","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"2026090221463581200_cit17","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/jps.21502","article-title":"Postprandial\nevolution in composition\nand characteristics of human duodenal fluids in different nutritional\nstates","volume":"98","author":"Clarysse","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"2026090221463581200_cit18","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1021\/mp100144v","article-title":"Simulating\nFasted Human Intestinal\nFluids: Understanding the Roles of Lecithin and Bile Acids","volume":"7","author":"Soderlind","year":"2010","journal-title":"Mol. Pharmaceutics"},{"issue":"11","key":"2026090221463581200_cit19","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1111\/j.2042-7158.2010.01023.x","article-title":"Characterising\nthe behaviour of poorly\nwater soluble drugs in the intestine: application of biorelevant media\nfor solubility, dissolution and transport studies","volume":"62","author":"Kleberg","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"issue":"10","key":"2026090221463581200_cit20","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1021\/acs.molpharmaceut.6b00496","article-title":"An In-Depth\nView into Human Intestinal\nFluid Colloids: Intersubject Variability in Relation to Composition","volume":"13","author":"Riethorst","year":"2016","journal-title":"Mol. Pharmaceutics"},{"issue":"11","key":"2026090221463581200_cit21","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1002\/jps.22154","article-title":"Drug supersaturation\nin simulated\nand human intestinal fluids representing different nutritional states","volume":"99","author":"Bevernage","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"2026090221463581200_cit22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejps.2014.10.019","article-title":"Statistical\ninvestigation of simulated intestinal fluid composition on the equilibrium\nsolubility of biopharmaceutics classification system class II drugs","volume":"67","author":"Khadra","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"2026090221463581200_cit23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejps.2016.12.008","article-title":"Statistical\ninvestigation of simulated fed intestinal media composition on the\nequilibrium solubility of oral drugs","volume":"99","author":"Zhou","year":"2017","journal-title":"Eur. J.\nPharm. Sci."},{"issue":"9","key":"2026090221463581200_cit24","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.bbamem.2013.05.020","article-title":"Phase diagram\nof a 4-component lipid mixture: DSPC\/DOPC\/POPC\/chol","volume":"1828","author":"Konyakhina","year":"2013","journal-title":"Biochim. Biophys. Acta, Biomembr."},{"issue":"2","key":"2026090221463581200_cit25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jcis.2009.03.047","article-title":"Assessment\nof solubilization characteristics of different surfactants for carvedilol\nphosphate as a function of pH","volume":"335","author":"Chakraborty","year":"2009","journal-title":"J. Colloid Interface\nSci."},{"issue":"3","key":"2026090221463581200_cit26","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/0006-3002(63)90754-6","article-title":"BEHAVIOR\nAND SOLUBILITY OF MONOGLYCERIDES IN DILUTE, MICELLAR BILE-SALT SOLUTION","volume":"70","author":"Hofmann","year":"1963","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"2026090221463581200_cit27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0928-0987(01)00182-8","article-title":"A dynamic in vitro\nlipolysis model II: Evaluation of the model","volume":"14","author":"Zangenberg","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"2026090221463581200_cit28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/jps.20494","article-title":"Biorelevant dissolution\nmedia: aggregation\nof amphiphiles and solubility of estradiol","volume":"95","author":"Ilardia-Arana","year":"2006","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"2026090221463581200_cit29","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ejps.2011.04.016","article-title":"Intestinal\ndrug solubility estimation based on simulated intestinal fluids: comparison\nwith solubility in human intestinal fluids","volume":"43","author":"Clarysse","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"2026090221463581200_cit30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/jphp.12336","article-title":"Structural\nfeatures of colloidal species in the human fasted upper small intestine","volume":"67","author":"Mullertz","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"2026090221463581200_cit31","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/jps.10329","article-title":"Separation and characterization\nof the colloidal phases produced on digestion of common formulation\nlipids and assessment of their impact on the apparent solubility of\nselected poorly water-soluble drugs","volume":"92","author":"Kossena","year":"2003","journal-title":"J. Pharm.\nSci."},{"issue":"2","key":"2026090221463581200_cit32","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s11095-014-1487-z","article-title":"Computational\nprediction of drug solubility in fasted simulated and aspirated human\nintestinal fluid","volume":"32","author":"Fagerberg","year":"2015","journal-title":"Pharm. Res."},{"issue":"5","key":"2026090221463581200_cit33","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jpba.2010.03.004","article-title":"Analytical\nissues in HPLC\/MS\/MS simultaneous assay of furosemide, spironolactone\nand canrenone in human plasma samples","volume":"52","author":"Sora","year":"2010","journal-title":"J. Pharm.\nBiomed. Anal."},{"issue":"1","key":"2026090221463581200_cit34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1023\/A:1016062224568","article-title":"Estimation\nof the\nincrease in solubility of drugs as a function of bile salt concentration","volume":"13","author":"Mithani","year":"1996","journal-title":"Pharm. Res."},{"issue":"3","key":"2026090221463581200_cit35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0939-6411(98)00037-X","article-title":"Increasing drug solubility by means of bile salt-phosphatidylcholine-based\nmixed micelles","volume":"46","author":"Hammad","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"12","key":"2026090221463581200_cit36","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1007\/s11095-013-1206-1","article-title":"Glyceride\nlipid formulations: molecular dynamics modeling of phase behavior\nduring dispersion and molecular interactions between drugs and excipients","volume":"30","author":"Warren","year":"2013","journal-title":"Pharm. Res."},{"issue":"5","key":"2026090221463581200_cit37","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1002\/hep.1840040814","article-title":"THE IONIZATION\nBEHAVIOR OF FATTY-ACIDS AND BILE-ACIDS IN MICELLES AND MEMBRANES","volume":"4","author":"Small","year":"1984","journal-title":"Hepatology"},{"issue":"7","key":"2026090221463581200_cit38","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1021\/la00007a020","article-title":"AGGREGATE STRUCTURE IN DILUTE AQUEOUS\nDISPERSIONS OF OLEIC-ACID SODIUM OLEATE AND OLEIC-ACID SODIUM OLEATE\nEGG PHOSPHATIDYLCHOLINE","volume":"11","author":"Edwards","year":"1995","journal-title":"Langmuir"},{"issue":"2","key":"2026090221463581200_cit39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2174\/1389557053402701","article-title":"The impact\nof lipophilicity in drug research: A case report on beta-blockers","volume":"5","author":"Mannhold","year":"2005","journal-title":"Mini-Rev. Med. Chem."},{"issue":"2","key":"2026090221463581200_cit40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1208\/s12249-008-9055-7","article-title":"Carvedilol: Solubilization\nand cyclodextrin complexation: A technical note","volume":"9","author":"Loftsson","year":"2008","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"2026090221463581200_cit41","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/archderm.1963.01590140038006","article-title":"EFFECTIVE\nUSE OF GRISEOFULVIN","volume":"87","author":"Crounse","year":"1963","journal-title":"Arch. Dermatol."},{"issue":"2","key":"2026090221463581200_cit42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/jps.10554","article-title":"Probing\ndrug solubilization patterns in the gastrointestinal tract after administration\nof lipid-based delivery systems: A phase diagram approach","volume":"93","author":"Kossena","year":"2004","journal-title":"J. Pharm. Sci."},{"issue":"11","key":"2026090221463581200_cit43","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3109\/03639045.2012.737331","article-title":"Inclusion\ncomplex of aprepitant with\ncyclodextrin: evaluation of physico-chemical and pharmacokinetic properties","volume":"39","author":"Ridhurkar","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"2026090221463581200_cit44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1023\/A:1013651215061","article-title":"Influence of hydrodynamics\nand particle size on the absorption of felodipine in labradors","volume":"19","author":"Scholz","year":"2002","journal-title":"Pharm. Res."},{"key":"2026090221463581200_cit45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejps.2016.05.026","article-title":"Supersaturation of\nzafirlukast in fasted and fed state intestinal media with and without\nprecipitation inhibitors","volume":"91","author":"Madsen","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"2026090221463581200_cit46","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1021\/ac9810563","article-title":"Hydrophobicity of\nionizable compounds. A theoretical study and measurements of diuretic\noctanol-water partition coefficients by countercurrent chromatography","volume":"71","author":"Berthod","year":"1999","journal-title":"Anal. Chem."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.7b00354","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/14\/12\/4132\/67090904\/acs.molpharmaceut.7b00354.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/14\/12\/4132\/67090904\/acs.molpharmaceut.7b00354.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:49:34Z","timestamp":1788400174000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/14\/12\/4132\/680528\/Influence-of-Physiological-Gastrointestinal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":46,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,7,27]]},"published-print":{"date-parts":[[2017,12,4]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00354","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]}}}